Cite
HARVARD Citation
Rymkiewicz, G. et al. (n.d.). R‐CHOP is not effective regimen in CD5(+)DLBCL diagnosed by flow‐cytometry/immunohistochemistry, karyotype and BCL2/BCL6 status and expression. Hematological oncology. pp. 333-334. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rymkiewicz, G. et al. (n.d.). R‐CHOP is not effective regimen in CD5(+)DLBCL diagnosed by flow‐cytometry/immunohistochemistry, karyotype and BCL2/BCL6 status and expression. Hematological oncology. pp. 333-334. [Online].